These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 17000292)
1. Different patterns of aortic wall elasticity in patients with Marfan syndrome: a noninvasive follow-up study. Baumgartner D; Baumgartner C; Schermer E; Engl G; Schweigmann U; Mátyás G; Steinmann B; Stein JI J Thorac Cardiovasc Surg; 2006 Oct; 132(4):811-9. PubMed ID: 17000292 [TBL] [Abstract][Full Text] [Related]
2. Effects of aging on aortic diameters and distensibility in Marfan's syndrome: comparison with healthy subjects. Ichihashi K J Cardiol; 2000 Jan; 35(1):19-26. PubMed ID: 10654246 [TBL] [Abstract][Full Text] [Related]
3. Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome. Yetman AT; Bornemeier RA; McCrindle BW Am J Cardiol; 2005 May; 95(9):1125-7. PubMed ID: 15842990 [TBL] [Abstract][Full Text] [Related]
4. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Chung AW; Yang HH; Radomski MW; van Breemen C Circ Res; 2008 Apr; 102(8):e73-85. PubMed ID: 18388324 [TBL] [Abstract][Full Text] [Related]
5. Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome. Nollen GJ; Groenink M; Tijssen JG; Van Der Wall EE; Mulder BJ Eur Heart J; 2004 Jul; 25(13):1146-52. PubMed ID: 15231373 [TBL] [Abstract][Full Text] [Related]
6. [Compliance of the normal-sized aorta in adolescents with Marfan syndrome: comparison of MR measurements of aortic distensibility and pulse wave velocity]. Eichhorn JG; Krissak R; Rüdiger HJ; Ley S; Arnold R; Boese J; Krug R; Gorenflo M; Khalil M; Ulmer H; Kauczor HU; Fink C Rofo; 2007 Aug; 179(8):841-6. PubMed ID: 17638174 [TBL] [Abstract][Full Text] [Related]
7. Beta-blocking therapy in patients with the Marfan syndrome and entire aortic replacement. Meijboom LJ; Westerhof BE; Nollen GJ; Spaan JA; de Mol BA; Jacobs MJ; Mulder BJ Eur J Cardiothorac Surg; 2004 Nov; 26(5):901-6. PubMed ID: 15519180 [TBL] [Abstract][Full Text] [Related]
8. Aortic distensibility and dimensions and the effects of growth hormone treatment in the turner syndrome. van den Berg J; Bannink EM; Wielopolski PA; Pattynama PM; de Muinck Keizer-Schrama SM; Helbing WA Am J Cardiol; 2006 Jun; 97(11):1644-9. PubMed ID: 16728230 [TBL] [Abstract][Full Text] [Related]
9. [Study of the efficacy and safety of losartan versus atenolol for aortic dilation in patients with Marfan syndrome]. Forteza A; Evangelista A; Sánchez V; Teixidó G; García D; Sanz P; Gutiérrez L; Centeno J; Rodríguez-Palomares J; Cortina J; García-Dorado D Rev Esp Cardiol; 2011 Jun; 64(6):492-8. PubMed ID: 21561700 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic power of aortic elastic properties in young patients with Marfan syndrome. Baumgartner D; Baumgartner C; Mátyás G; Steinmann B; Löffler-Ragg J; Schermer E; Schweigmann U; Baldissera I; Frischhut B; Hess J; Hammerer I J Thorac Cardiovasc Surg; 2005 Apr; 129(4):730-9. PubMed ID: 15821637 [TBL] [Abstract][Full Text] [Related]
11. Effect of long-term beta-blockade on aortic root compliance in patients with Marfan syndrome. Rios AS; Silber EN; Bavishi N; Varga P; Burton BK; Clark WA; Denes P Am Heart J; 1999 Jun; 137(6):1057-61. PubMed ID: 10347331 [TBL] [Abstract][Full Text] [Related]
12. Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. Groenink M; de Roos A; Mulder BJ; Spaan JA; van der Wall EE Am J Cardiol; 1998 Jul; 82(2):203-8. PubMed ID: 9678292 [TBL] [Abstract][Full Text] [Related]
13. Valve-sparing and valve-replacing techniques for aortic root replacement in patients with Marfan syndrome: Analysis of early outcome. Volguina IV; Miller DC; LeMaire SA; Palmero LC; Wang XL; Connolly HM; Sundt TM; Bavaria JE; Dietz HC; Milewicz DM; Coselli JS; J Thorac Cardiovasc Surg; 2009 May; 137(5):1124-32. PubMed ID: 19379977 [TBL] [Abstract][Full Text] [Related]
14. Prophylactiv use of propranolol in the Marfan syndrome to prevent aortic dissection. Ose L; McKusick VA Birth Defects Orig Artic Ser; 1977; 13(3C):163-9. PubMed ID: 19114 [TBL] [Abstract][Full Text] [Related]
15. Beta-blocker therapy does not alter the rate of aortic root dilation in pediatric patients with Marfan syndrome. Selamet Tierney ES; Feingold B; Printz BF; Park SC; Graham D; Kleinman CS; Mahnke CB; Timchak DM; Neches WH; Gersony WM J Pediatr; 2007 Jan; 150(1):77-82. PubMed ID: 17188619 [TBL] [Abstract][Full Text] [Related]
16. Long-term experience of girdling the ascending aorta with Dacron mesh as definitive treatment for aneurysmal dilation. Cohen O; Odim J; De la Zerda D; Ukatu C; Vyas R; Vyas N; Palatnik K; Laks H Ann Thorac Surg; 2007 Feb; 83(2):S780-4; discussion S785-90. PubMed ID: 17257926 [TBL] [Abstract][Full Text] [Related]
18. The Ghent Marfan Trial--a randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with β-blockers. Möberg K; De Nobele S; Devos D; Goetghebeur E; Segers P; Trachet B; Vervaet C; Renard M; Coucke P; Loeys B; De Paepe A; De Backer J Int J Cardiol; 2012 Jun; 157(3):354-8. PubMed ID: 21239069 [TBL] [Abstract][Full Text] [Related]
19. Elastic properties of the reconstructed aorta in hypoplastic left heart syndrome. Cardis BM; Fyfe DA; Mahle WT Ann Thorac Surg; 2006 Mar; 81(3):988-91. PubMed ID: 16488707 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the Effect of Aliskiren Versus Negative Controls on Aortic Stiffness in Patients With Marfan Syndrome Under Treatment With Atenolol. Hwang JW; Kim EK; Jang SY; Chung TY; Ki CS; Sung K; Kim SM; Ahn J; Carriere K; Choe YH; Chang SA; Kim DK Rev Esp Cardiol (Engl Ed); 2018 Sep; 71(9):743-749. PubMed ID: 29198406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]